Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
07962436001 Dna Kapa Hyperplus Kit QTY32 is a federal award for Army Med Res Acq Activity held by Roche Diagnostics Corp. Estimated value $125K ($125K obligated). Current period of performance ends Mar 28, 2024. Place of performance: INDIANAPOLIS IN. Related solicitation W81XWH22Q0151.
07962436001 dna kapa hyperplus kit qty32. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Mar 28, 2024 (937 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT942524F0106? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942524F0106?
HT942524F0106 (07962436001 dna kapa hyperplus kit qty32) is a Army Med Res Acq Activity award with a potential value of $125K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-24-F-0106?
HT9425-24-F-0106 is the dashed form of PIID HT942524F0106 (07962436001 dna kapa hyperplus kit qty32), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942524F0106?
Army Med Res Acq Activity awarded HT942524F0106 to Roche Diagnostics Corp (potential $125K).
Who is the incumbent on HT942524F0106?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Mar 28, 2024.
When does Roche Diagnostics Corp’s HT942524F0106 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 28, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT942524F0106? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.